Literature DB >> 14755731

Deterioration of naming nouns versus verbs in primary progressive aphasia.

Argye E Hillis1, Sangjin Oh, Lynda Ken.   

Abstract

Disproportionate impairment of naming nouns versus verbs and the opposite pattern have been reported in cases of focal brain damage or degenerative disease, indicating that processing of nouns and verbs may rely on different brain regions. However, it has not been clear whether it is the spoken word forms or the meanings (or both) of nouns and verbs that depend on separate neural regions. We tested oral and written naming of nouns and verbs, matched in difficulty, in patients with nonfluent primary progressive aphasia (nonfluent PPA; n = 15), fluent primary progressive aphasia (fluent PPA; n = 7), and amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD; n = 6). Patients with nonfluent PPA and ALS-FTD, both individually and as groups, were significantly more impaired on verb naming than on noun naming and significantly more impaired on oral naming than written naming. Patients with fluent PPA showed the opposite pattern for both word class and modality, significantly more impaired naming of nouns versus verbs and significantly more impaired written versus oral naming. Results indicate that separate regions of the brain are essential for access to oral and written word forms of verbs and nouns, and that these neural regions can be differentially damaged in separate forms of PPA.

Entities:  

Mesh:

Year:  2004        PMID: 14755731     DOI: 10.1002/ana.10812

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  52 in total

1.  Covert processing of words and pictures in nonsemantic variants of primary progressive aphasia.

Authors:  Emily Rogalski; Alfred Rademaker; Marsel Mesulam; Sandra Weintraub
Journal:  Alzheimer Dis Assoc Disord       Date:  2008 Oct-Dec       Impact factor: 2.703

2.  Treatment of Primary Progressive Aphasia.

Authors:  Donna C Tippett; Argye E Hillis; Kyrana Tsapkini
Journal:  Curr Treat Options Neurol       Date:  2015-08       Impact factor: 3.598

Review 3.  The neuropsychological profile of Alzheimer disease.

Authors:  Sandra Weintraub; Alissa H Wicklund; David P Salmon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

4.  Inflectional morphology in primary progressive aphasia: an elicited production study.

Authors:  Stephen M Wilson; Temre H Brandt; Maya L Henry; Miranda Babiak; Jennifer M Ogar; Chelsey Salli; Lisa Wilson; Karen Peralta; Bruce L Miller; Maria Luisa Gorno-Tempini
Journal:  Brain Lang       Date:  2014-08-16       Impact factor: 2.381

5.  Frontal lobe damage impairs process and content in semantic memory: evidence from category-specific effects in progressive non-fluent aphasia.

Authors:  Jamie Reilly; Amy D Rodriguez; Jonathan E Peelle; Murray Grossman
Journal:  Cortex       Date:  2010-06-01       Impact factor: 4.027

Review 6.  The non-fluent/agrammatic variant of primary progressive aphasia.

Authors:  Murray Grossman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

7.  Non-Fluent Speech in Frontotemporal Lobar Degeneration.

Authors:  Sharon Ash; Peachie Moore; Luisa Vesely; Delani Gunawardena; Corey McMillan; Chivon Anderson; Brian Avants; Murray Grossman
Journal:  J Neurolinguistics       Date:  2009-07-01       Impact factor: 1.710

8.  Grammatical Impairments in PPA.

Authors:  Cynthia K Thompson; Jennifer E Mack
Journal:  Aphasiology       Date:  2014-09       Impact factor: 2.773

Review 9.  Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes.

Authors:  Michał Harciarek; Stephanie Cosentino
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 10.  Primary progressive aphasia and the evolving neurology of the language network.

Authors:  M-Marsel Mesulam; Emily J Rogalski; Christina Wieneke; Robert S Hurley; Changiz Geula; Eileen H Bigio; Cynthia K Thompson; Sandra Weintraub
Journal:  Nat Rev Neurol       Date:  2014-09-02       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.